<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25054766</article-id>
      <article-id pub-id-type="pmc">4148293</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20142646</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Syndrome in Question</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Syndrome in Question<sup><xref ref-type="fn" rid="fn01">*</xref></sup></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Meireles</surname>
            <given-names>Sheila Itamara Ferreira do Couto</given-names>
          </name>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Andrade</surname>
            <given-names>S&#xF4;nia Maria Fonseca</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gomes</surname>
            <given-names>Maria Fernanda</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Castro</surname>
            <given-names>Fernanda Almeida Nunes</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tebcherani</surname>
            <given-names>Antonio Jos&#xE9;</given-names>
          </name>
        </contrib>
        <aff> Complexo Hospitalar Padre Bento de Guarulhos - Guarulhos (SP), Brazil. </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Sheila Itamara Ferreira do Couto Meireles,
Avenida Em&#xED;lio Ribas, 1819. 07051-000 - Guarulhos - SP, Brazil. E-mail:
<email>sheilaifc@bol.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jul-Aug</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jul-Aug</season>
        <year>2014</year>
      </pub-date>
      <volume>89</volume>
      <issue>4</issue>
      <fpage>679</fpage>
      <lpage>680</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>3</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>7</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>Rendu-Osler-Weber Syndrome also known as Hereditary Hemorrhagic Telangiectasia is
a rare systemic fibrovascular dysplasia, with dominant autosomal inheritance. It
is characterized by recurrent epistaxis, mucocutaneous telangiectasia, visceral
arteriovenous malformation and positive family history. There may be
hematologic, neurologic, dermatologic and gastrointestinal complications.
Therapy is supportive and aimed at preventing complications. In this article we
report a case of Rendu-Osler-Weber in a 64 year-old man, with history of
mucocutaneous telangiectasia since the third decade of life, recurrent
epistaxis, positive family history and vascular ectasia in the gastrointestinal
tract.</p>
      </abstract>
      <kwd-group>
        <kwd>Arteriovenous fistula</kwd>
        <kwd>Epistaxis</kwd>
        <kwd>Gastrointestinal hemorrhage</kwd>
        <kwd>Skin abnormalities</kwd>
        <kwd>Skin diseases, vascular</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>CASE REPORT</title>
      <p>Sixty-four year old male reports lesions in hands and oral cavity for nearly 40
years, accompanied by recurring epistaxis that became progressively more severe,
culminating in hospital admission during the last episode. He denies
gastrointestinal bleeding and refers that his father had a similar case.
Dermatological examination: telangiectasia in fingertips, tongue, lips, perioral and
nasal regions (<xref ref-type="fig" rid="f01">Figures 1</xref> and <xref ref-type="fig" rid="f02">2</xref>). Anatomopathological exam of fingertip skin
showed histological skin sections with epidermal acanthosis and a thick layer of
compact hyperorthokeratosis, numerous vessels with tortuous and ectatic lumen were
noted in the dermis, sometimes touching and compressing the basal layer of the
epidermis. These vessels are lined by endothelial cells without atypias and have
variable calibers (<xref ref-type="fig" rid="f03">Figure 3</xref>). Colonoscopy
showed vascular ectasia in the sigmoid. Magnetic resonance angiography of brain,
chest and abdomen, and upper gastrointestinal endoscopy showed no vascular
alterations.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Erythematous-violaceous papules with teleangiectasias in tongue</p>
        </caption>
        <graphic xlink:href="abd-89-04-0679-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Teleangiectasias in fingertips and palms</p>
        </caption>
        <graphic xlink:href="abd-89-04-0679-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Anatomopathological exam of fingertip skin lesion: numerous vessels with
tortuous and ectatic lumen were noted in the dermis, sometimes touching and
compressing the basal layer of the epidermis. The vessels are lined by
endothelial cells without atypias and have variable calibers</p>
        </caption>
        <graphic xlink:href="abd-89-04-0679-g03"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The patient reported was classified as having Rendu-Osler-Weber syndrome for
presenting more than three of the four diagnostic criteria: spontaneous and
recurrent epistaxis, multiple visible telangiectasias (lips, tongue, hands and
nose); visceral lesion (gastrointestinal telangiectasias) and positive family
history (first-degree relative as disease carrier).</p>
      <p>Rendu-Osler-Weber syndrome, also known as Hereditary Hemorrhagic Telangiectasia
(HHT), is a rare systemic fibrovascular dysplasia that leaves vascular walls
vulnerable to trauma and rupture, causing mucocutaneous bleeding.<sup><xref rid="r01" ref-type="bibr">1</xref>-<xref rid="r03" ref-type="bibr">3</xref></sup> It has a dominant autosomal inheritance, but in 20% of cases
there is no positive familial history.<sup><xref rid="r03" ref-type="bibr">3</xref></sup> HHT can arise from mutations in at least five genes, but
mutations in two genes (ENG and ACVRL1/ALK1) represent approximately 85% of
cases.<sup><xref rid="r04" ref-type="bibr">4</xref></sup> The incidence is
variable and affects both genders.<sup><xref rid="r01" ref-type="bibr">1</xref>-<xref rid="r03" ref-type="bibr">3</xref></sup></p>
      <p>Diagnosis is based on the presence of at least three of the following criteria:
recurrent epistaxis, mucocutaneous telangiectasias; evidence of family history and
visceral arteriovenous malformations.<sup><xref rid="r01" ref-type="bibr">1</xref>-<xref rid="r04" ref-type="bibr">4</xref></sup> Recurrent epistaxis
is the first and main symptom and it is present in about 90% of cases. Patients with
this syndrome can develop telangiectasias on skin, nasal and oral mucosae,
gastrointestinal tract and also arteriovenous fistulae in lung, liver and
brain.<sup><xref rid="r03" ref-type="bibr">3</xref></sup> Investigation of
these alterations should be done through endoscopy, colonoscopy and MRI of head,
thorax and abdomen.</p>
      <p>Mortality rate increases in patients over 60 years old, however, the disease is
characterized by the high morbidity among younger patients due to visceral
involvement, particularly lungs and brain.<sup><xref rid="r05" ref-type="bibr">5</xref></sup> Treatment consists of supportive care and prevention of
complications. Angiogenesis modulation therapy may be an effective
alternative.<sup><xref rid="r04" ref-type="bibr">4</xref></sup> Bevacizumab
(recombinant humanized monoclonal endothelial growth antibody - VEGF) has been used
as a treatment option in these patients.<sup><xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r07" ref-type="bibr">7</xref></sup> Several other
treatment options such as propranolol, tranexamic acid, and other forms of laser
ablation have been reported in the literature, with varying response
rates.<sup><xref rid="r05" ref-type="bibr">5</xref>-<xref rid="r08" ref-type="bibr">8</xref></sup></p>
      <p>The Rendu-Osler-Weber syndrome is a rare disease that should be well understood by
dermatologists, because the correct diagnosis of a patient at the start of symptoms
and his early referral to a multidisciplinary team can avoid more severe disease
complications.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Meireles SIFC, Andrade SMF, Gomes MF, Castro FAN,
Tebcherani AJ. Do you know this syndrome? Rendu-Osler-Weber Syndrome. An Bras
Dermatol. 2014;89(4):679-80.</p>
      </fn>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p>Work performed at Complexo Hospitalar Padre Bento de Guarulhos - Guarulhos (SP),
Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>dos Santos</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Dalcin</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Neves</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Mann</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Pretto</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Bertolazi</surname>
              <given-names>AN</given-names>
            </name>
          </person-group>
          <article-title>Hereditary hemorrhagic telangiectasia: a rare cause of severe
anemia</article-title>
          <source>J Bras Pneumol</source>
          <year>2007</year>
          <volume>33</volume>
          <fpage>109</fpage>
          <lpage>112</lpage>
          <pub-id pub-id-type="pmid">17568877</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Providencia</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cachulo</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>GV</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lemos</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Leit&#xE3;o-Marques</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Telangiectasia Heredit&#xE1;ria Hemorr&#xE1;gica: causa rara
de Hipertens&#xE3;o Pulmonar</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2010</year>
          <volume>94</volume>
          <fpage>94</fpage>
          <lpage>96</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Juares</surname>
              <given-names>AJC</given-names>
            </name>
            <name>
              <surname>Aringa</surname>
              <given-names>ARD</given-names>
            </name>
            <name>
              <surname>Nardi</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Kobari</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>VLMGM</given-names>
            </name>
            <name>
              <surname>Perches</surname>
              <given-names>RM</given-names>
              <suffix>Filho</suffix>
            </name>
          </person-group>
          <article-title xml:lang="pt">S&#xED;ndrome de Rendu-Osler-Weber: relato de caso e
revis&#xE3;o da literature</article-title>
          <source>Rev Bras Otorrinolaringol</source>
          <year>2008</year>
          <volume>74</volume>
          <fpage>452</fpage>
          <lpage>457</lpage>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duffau</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lazarro</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Viallard</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
          <article-title>Hereditary hemorrhagic telangiectasia</article-title>
          <source>Rev Med Interne</source>
          <year>2014</year>
          <volume>35</volume>
          <fpage>21</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="pmid">23517771</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Albuquerque</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>CRSC</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Terra</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Quinete</surname>
              <given-names>SS</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Telangiectasia hemorr&#xE1;gica heredit&#xE1;ria: &#xE1;cido
tranex&#xE2;mico no tratamento de &#xFA;lcera plantar</article-title>
          <source>An Bras Dermatol</source>
          <year>2005</year>
          <volume>80</volume>
          <fpage>S373</fpage>
          <lpage>S375</lpage>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lupu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Stefanescu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Treton</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Attar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Corcos</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Bouhnik</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Bevacizumab as rescue treatment for severe recurrent
gastrointestinal bleeding in hereditary hemorrhagic
telangiectasia</article-title>
          <source>J Clin Gastroenterol</source>
          <year>2013</year>
          <volume>47</volume>
          <fpage>256</fpage>
          <lpage>257</lpage>
          <pub-id pub-id-type="pmid">23164683</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rohrmeier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>K&#xFC;hnel</surname>
              <given-names>TS</given-names>
            </name>
          </person-group>
          <article-title>Bevacizumab in therapy-refractory epistaxis: case report of
low-dose antibody therapy for hereditary hemorrhagic
telangiectasia</article-title>
          <source>HNO</source>
          <year>2012</year>
          <volume>60</volume>
          <fpage>1003</fpage>
          <lpage>1006</lpage>
          <pub-id pub-id-type="pmid">22706563</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Breier</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Propanolol and angiogenesis inhibition in hereditary haemorrhagic
telangiectasia</article-title>
          <source>Thromb Haemost</source>
          <year>2012</year>
          <volume>108</volume>
          <fpage>1</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">22628061</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
